Precision Oncology Drug Yields Impressive Results, Showing Power Of Cancer Genomics

It’s a perfect example of how precision medicine can benefit patients with rare conditions. The key to the positive results is molecular matching. Patients received larotrectinib, a TRK inhibitor, only if their cancers were marked by a fusion involving a TRK gene.

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive